Kurs
+2,50%
Kalender
| Tid* | ||
| 2025-02-12 | 09:00 | Bokslutskommuniké 2024 |
| 2024-11-13 | - | Extra Bolagsstämma 2024 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-01 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2024-06-28 | - | Årsstämma |
| 2024-06-14 | - | Bokslutskommuniké 2023 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-12 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2023-06-09 | - | Årsstämma |
| 2023-04-28 | - | Bokslutskommuniké 2022 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2022-06-09 | - | Årsstämma |
| 2022-04-29 | - | Bokslutskommuniké 2021 |
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2021-06-09 | - | Årsstämma |
| 2021-04-30 | - | Bokslutskommuniké 2020 |
| 2020-09-11 | - | Extra Bolagsstämma 2020 |
| 2020-08-26 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-04-15 | - | Bokslutskommuniké 2019 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-06 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2019-06-05 | - | Årsstämma |
| 2019-04-24 | - | Bokslutskommuniké 2018 |
| 2019-01-07 | - | Extra Bolagsstämma 2019 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-30 | - | Årsstämma |
| 2018-02-21 | - | Bokslutskommuniké 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-08 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
| 2017-06-07 | - | Årsstämma |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | X-dag bonusutdelning ABTEC 1 |
| 2016-11-17 | - | Extra Bolagsstämma 2016 |
| 2016-11-17 | - | 15-10 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-09 | - | X-dag ordinarie utdelning ABTEC 1.50 NOK |
| 2016-06-08 | - | Årsstämma |
| 2016-02-10 | - | Bokslutskommuniké 2015 |
| 2015-11-18 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-19 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-04 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
| 2015-06-03 | - | Årsstämma |
| 2015-05-13 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-11 | - | Bokslutskommuniké 2014 |
| 2014-11-26 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-20 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-11 | - | Årsstämma |
| 2014-05-21 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-11-27 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-21 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-06-12 | - | X-dag ordinarie utdelning |
| 2013-06-11 | - | Årsstämma |
| 2013-05-22 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-13 | - | Bokslutskommuniké 2012 |
| 2012-11-27 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-28 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-14 | - | Årsstämma |
| 2012-05-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-17 | - | Bokslutskommuniké 2011 |
| 2011-11-30 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-29 | - | Kvartalsrapport 2011-Q2 |
| 2011-06-17 | - | X-dag ordinarie utdelning |
| 2011-06-16 | - | Årsstämma |
| 2011-05-30 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-18 | - | Bokslutskommuniké 2010 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Bioteknik |
14.11.2024 13:47:20 CET | Aqua Bio Technology ASA | Innsideinformasjon
Aqua Bio Technology ASA (ABT or the Company) has engaged in a series of acquisitions in recent years. Following an analysis of the development milestones and additional investments required for Skinteam Norge AS (Skinteam) to achieve success, positive cash flow, and synergies for the rest of ABT's companies, ABT has decided to cease further funding for Skinteam. Instead, ABT will focus its liquidity on other group entities expected to generate positive cash flow by 2025. Efforts to transition Skinteam to new ownership have not resulted in a viable solution, and based on recent developments, it is anticipated that Skinteam’s board will now decide or accept to wind down operations.
The divestment from Skinteam is projected to result in a significant non-cash impairment charge due to the reduction of goodwill on the Group's balance sheet. However, this decision will improve ABT's liquidity and substantially decrease future capital requirements. Following the completion of the recent Private Placement, the Jetcarrier AS transaction, and the closure of Skinteam, ABT is positioned to emerge as a stronger entity. This strategic shift is expected to enhance value for shareholders and improve the financial health of the Group's remaining subsidiaries.
For further information, please contact Jan Varming, CFO, telephone +47 90 83 90 76.
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective, and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Informasjonspliktig opplysning
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven § 5-12.
Om Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABT) utvikler og kommersialiserer bærekraftig
bioteknologi for bruk i hudpleieprodukter. ABTs kosmetikkingredienser er svært
effektive og de representerer et naturlig alternativ til tradisjonelle
ingredienser for kosmetikkindustrien. ABT markedsfører og selger dessuten
naturlige hudpleieprodukter utviklet av partnere til konsumenter og
profesjonelle brukere. Aqua Bio Technology er notert på Euronext Expand.